Skip to content
healthcare.dev

Topiramate

NDC 76420-276, Topiramate, tablet, from Asclemed USA, Inc..

Product NDC
76420-276
Status
Listed
Labeler
Asclemed USA, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA076343
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/76420-276 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TOPIRAMATE50 mg/1

Pharmacologic classes

Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
76420-276-307642002763030 TABLET in 1 BOTTLE (76420-276-30)
76420-276-607642002766060 TABLET in 1 BOTTLE (76420-276-60)
76420-276-907642002769090 TABLET in 1 BOTTLE (76420-276-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4e476c33-3590-4c6f-981d-915623cdacf0

Use it

Look up 76420-276 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/76420-276 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 76420-276. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.